DALLAS, April 12, 2018 -- ASLMS 2018 ─ At the 2018 American Society for Laser Medicine and Surgery conference, Cutera, Inc. (Nasdaq:CUTR) (“Cutera” or the “Company”) celebrates 20 years of best-in-class product innovation with continued commitment to the industry and its providers. In conjunction with the 20th anniversary of the company, Cutera announces the global launch of the enlighten SR, a new picosecond platform specifically designed for skin revitalization and the treatment of benign pigmented lesions.
With more than 20 product introductions in 20 years, Cutera continues developing and providing scientifically advanced laser systems. The enlighten SR, is the latest product introduction which harnesses the power and versatility of the existing enlighten platform while offering practitioners a solution to address both photodamaged and aging skin.
“20 years ago, Cutera was founded with a simple goal: to offer industry-leading laser and light-based solutions that provide a compelling and lasting investment, uniquely designed for specific market segments. These products redefine functionality and offer our physician partners the widest range of clinical applications for the face and body,” said James Reinstein, CEO of Cutera Inc. “We are proud of the Company’s accomplishments, thankful for our customers who have put their trust in us, and we look forward to paving the way for the next 20 years of aesthetic innovation.”
“In addition to our commitment to innovation, we are equally committed to supporting causes that reflect the company’s core beliefs and values. To that end, we are honored to partner with the National Rosacea Society in support of National Rosacea Awareness Month. For every ‘like’ or ‘share’ on our Facebook and LinkedIn pages, Cutera will donate $1 to support rosacea awareness and education activities,” continued Reinstein. “Rosacea affects more than 16 million Americans and we are pleased to offer a solution like excel V, that can address rosacea, and other vascular skin conditions.”
During ASLMS, leading industry experts will be at Cutera booth #807 to share with attendees their experiences and best practices for running a successful practice. In addition, the following presenters will be sharing the latest clinical trends and studies during the podium sessions:
- Picosecond 1064nm laser treatment of pigmentation and photoaging in dark skin types, Neil Sadick, M.D., Weill Cornell College, New York, NY
- Impact of exposure time and post treatment massage on subcutaneous fat thickness reduction using a monopolar radiofrequency device, Ashish Bhatia, M.D., DuPage Medical Group, Naperville, IL
- A prospective, split-face, randomized study comparing picosecond laser to q-switched laser for treatment of epidermal and dermal pigmented lesions in Asians, Woraphong Manuskiatti, M.D., Department of Dermatology, Faculty of Medicine Siriraj Hospital Bangkok, Bangkoknoi, Thailand
- Prospective study of removing solar lentigines using picosecond 532nm Nd:YAG laser for Asian patients
Kei Negishi, M.D., PhD, Institute of Geriatrics, Tokyo Women’s Medical University, Shibuya, Tokyo, Japan
- Clinical evaluation of a novel picosecond 670nm wavelength for the treatment of benign pigmented lesions, Omar A. Ibrahimi, M.D., Connecticut Skin Institute, Stamford, CT
- Clinical evaluation of a novel picosecond 670nm wavelength for the treatment of multicolored tattoo, Omar A. Ibrahimi, M.D., Connecticut Skin Institute, Stamford, CT
- Safety and efficacy of a novel refractive lens array using a 1064nm picosecond laser for low impact treatment of skin texture and fine lines, Macrene Alexiades, M.D., PhD, Yale University School of Medicine, New York, NY
- 1064nm Nd:YAG laser for the treatment of basal cell carcinoma: determining long-term efficacy, Arisa E. Ortiz, M.D., University of California, San Diego
Additional Resources:
- 20th anniversary video
- 20th Anniversary infographic
- Partnership with the National Rosacea Society
- Follow us on social media: Facebook, Twitter and Instagram
About Cutera
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
Media Contact: Rebel Gail Communications
Alli Good: [email protected]; 212.675.8553
Cutera, Inc.
Sandra Gardiner
Chief Financial Officer
415-657-5500
[email protected]
Investor Relations
John Mills
ICR, Inc.
646-277-1254
[email protected]


FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Japan Earthquake Disrupts Auto and Chip Supply Chains
Same sparkle, different story: how lab-grown diamonds are transforming the market
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 



